The United States Formulation Development Outsourcing Market is set to surge from US$ 10.11 billion in 2024 to US$ 18.11 ...

Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...

Part one of the Biobeat Report 2026, released by research and analytics firm De Facto ahead of CPHI Frankfurt, the world’s ...

ACG showcased the expansion of its European presence, and Bora Pharmaceuticals participates in a discussion about CDMO ...

The new center is designed to support both Full-Time Equivalent (FTE) and Dedicated Project Capacity (DPC) engagement models, enabling flexible collaboration with global innovators from early ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

VitriVax Inc., a Boulder-based vaccine-formulation technology company, has raised $17.25 million in Series B financing.

MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) BEIJING, China, Oct. 23, 2025 /PRNewswire/ ...

New clinical findings from Peak Biome highlight how flavorless prebiotic fiber supplementation supports digestive regularity, gut microbiome balance, and overall intestinal comfort.

Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.